BiomEdit
Americas
Fishers
,
United States
Startup
FOUNDED
2022
HEADCOUNT
21-100
FUNDING
Series B
Keywords:
probiotics, antibodies, microbiome, synthetic_biology, AI/ML, archaea, animal_nutrition, bacteria
BUSINESS
Develops microbiome-derived probiotics, bioactives, and engineered microbial medicines for animal health, targeting disease prevention and performance enhancement in livestock. Founded April 2022 in Fishers, Indiana. Carved out from Elanco Animal Health (NYSE: ELAN) in partnership with Ginkgo Bioworks (via Ferment Co. company creation studio). Microbiome innovation company discovering, designing, and developing novel probiotics, microbiome-derived bioactives ("Biome-actives"), and engineered microbial medicines for animal health. Flagship product BE-101 (to be marketed as Optavant), a first-of-its-kind probiotic vectored antibody (pvAb) targeting Clostridium perfringens toxins causing necrotic enteritis in broiler chickens. Long-term strategic partnership with Nutreco for next-gen feed additives. Methane reduction platform in in vivo trials, reshapes rumen microbiome to outcompete methanogens.
BIOTECH INVOLVEMENT
Core; Indiana-based microbiome company carved out of Elanco (2022) developing microbiome-derived probiotics, bioactives, and engineered microbial medicines for livestock disease prevention and performance.
TECHNOLOGY PLATFORM
synthetic biology; microbiome engineering; explainable AI
PRIMARY PRODUCTS
Engineered probiotics and microbiome bioactives for animal health